scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1020744F |
P356 | DOI | 10.1371/JOURNAL.PONE.0120744 |
P932 | PMC publication ID | 4358991 |
P698 | PubMed publication ID | 25768285 |
P5875 | ResearchGate publication ID | 273952059 |
P2093 | author name string | Jan Nilsson | |
Björn Fagerberg | |||
Gunilla Nordin Fredrikson | |||
Ragnar Alm | |||
Ulrica Prahl Gullberg | |||
P2860 | cites work | Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 |
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease | Q31135767 | ||
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 | ||
Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. | Q31807209 | ||
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis | Q33207408 | ||
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis | Q33890402 | ||
High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes | Q33930928 | ||
The immune system in atherosclerosis | Q34164644 | ||
Immunomodulation of atherosclerosis: implications for vaccine development | Q34363173 | ||
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review | Q34535616 | ||
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study | Q35212898 | ||
Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. | Q50859025 | ||
Are serum adiponectin concentrations in a population sample of 64-year-old Caucasian women with varying glucose tolerance associated with ultrasound-assessed atherosclerosis? | Q51491965 | ||
Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits | Q71231757 | ||
Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease | Q71730634 | ||
Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications | Q74440973 | ||
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events | Q79533802 | ||
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression | Q80417831 | ||
Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques | Q81652647 | ||
A higher level of IgM anti-oxidized LDL antibodies is associated with a lower severity of coronary atherosclerosis in patients on statins | Q82219199 | ||
Anti-oxidized LDL antibody levels are reduced in women with hypertension | Q84392366 | ||
Autoimmunity in atherosclerosis: a protective response losing control? | Q37138017 | ||
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes | Q37207913 | ||
Inflammation and immunity in diabetic vascular complications | Q37260195 | ||
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice | Q37385727 | ||
Association between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysis | Q40016955 | ||
Induction of T-cell activation by oxidized low density lipoprotein | Q41940298 | ||
Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance. | Q43023757 | ||
High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism | Q43120687 | ||
Percentage white: a new feature for ultrasound classification of plaque echogenicity in carotid artery atherosclerosis | Q43217020 | ||
Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis | Q43550562 | ||
Autoantibodies against modified low-density lipoproteins in coronary artery disease | Q44125644 | ||
Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis | Q44608860 | ||
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events | Q46125332 | ||
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. | Q46326610 | ||
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies | Q46376396 | ||
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction | Q46457217 | ||
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study | Q46517010 | ||
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension | Q46820023 | ||
Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests | Q46917189 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
P304 | page(s) | e0120744 | |
P577 | publication date | 2015-03-13 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women | |
P478 | volume | 10 |
Q59335211 | Associations between circulating IgG antibodies to Apolipoprotein B-derived peptide antigens and acute coronary syndrome in a Chinese Han population |
Q41732468 | Building Evidence Implicating Novel Cardiovascular Biomarkers in Obstructive Sleep Apnea |
Q90298329 | Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population |
Q92357470 | Lipoprotein(a) Elevation: A New Diagnostic Code with Relevance to Service Members and Veterans |
Q92340615 | Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment |
Q28553042 | Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect |
Search more.